📋 Tender Overview
The contract involves the conclusion of a non-exclusive discount agreement for the active ingredient allergen extract from meadow fescue, ryegrass, etc., ATC V01AA02, for the period from October 1, 2026, to September 30, 2028. The DAK-Gesundheit intends to conclude discount agreements with all interested pharmaceutical companies for the specified active ingredient until the new discount agreements come into effect. Allergen extract from meadow fescue, ryegrass, meadow foxtail, perennial ryegrass, and meadow ricegrass pollen, ATC V01AA02
